Cargando…

National Monkeypox Surveillance, Central African Republic, 2001–2021

We analyzed monkeypox disease surveillance in Central African Republic (CAR) during 2001–2021. Surveillance data show 95 suspected outbreaks, 40 of which were confirmed as monkeypox, comprising 99 confirmed and 61 suspected monkeypox cases. After 2018, CAR’s annual rate of confirmed outbreaks increa...

Descripción completa

Detalles Bibliográficos
Autores principales: Besombes, Camille, Mbrenga, Festus, Schaeffer, Laura, Malaka, Christian, Gonofio, Ella, Landier, Jordi, Vickos, Ulrich, Konamna, Xavier, Selekon, Benjamin, Dankpea, Joella Namsenei, Von Platen, Cassandre, Houndjahoue, Franck Gislain, Ouaïmon, Daniel Sylver, Hassanin, Alexandre, Berthet, Nicolas, Manuguerra, Jean-Claude, Gessain, Antoine, Fontanet, Arnaud, Nakouné-Yandoko, Emmanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707566/
https://www.ncbi.nlm.nih.gov/pubmed/36328951
http://dx.doi.org/10.3201/eid2812.220897
_version_ 1784840727052681216
author Besombes, Camille
Mbrenga, Festus
Schaeffer, Laura
Malaka, Christian
Gonofio, Ella
Landier, Jordi
Vickos, Ulrich
Konamna, Xavier
Selekon, Benjamin
Dankpea, Joella Namsenei
Von Platen, Cassandre
Houndjahoue, Franck Gislain
Ouaïmon, Daniel Sylver
Hassanin, Alexandre
Berthet, Nicolas
Manuguerra, Jean-Claude
Gessain, Antoine
Fontanet, Arnaud
Nakouné-Yandoko, Emmanuel
author_facet Besombes, Camille
Mbrenga, Festus
Schaeffer, Laura
Malaka, Christian
Gonofio, Ella
Landier, Jordi
Vickos, Ulrich
Konamna, Xavier
Selekon, Benjamin
Dankpea, Joella Namsenei
Von Platen, Cassandre
Houndjahoue, Franck Gislain
Ouaïmon, Daniel Sylver
Hassanin, Alexandre
Berthet, Nicolas
Manuguerra, Jean-Claude
Gessain, Antoine
Fontanet, Arnaud
Nakouné-Yandoko, Emmanuel
author_sort Besombes, Camille
collection PubMed
description We analyzed monkeypox disease surveillance in Central African Republic (CAR) during 2001–2021. Surveillance data show 95 suspected outbreaks, 40 of which were confirmed as monkeypox, comprising 99 confirmed and 61 suspected monkeypox cases. After 2018, CAR’s annual rate of confirmed outbreaks increased, and 65% of outbreaks occurred in 2 forested regions bordering the Democratic Republic of the Congo. The median patient age for confirmed cases was 15.5 years. The overall case-fatality ratio was 7.5% (12/160) for confirmed and suspected cases, 9.6% (8/83) for children <16 years of age. Decreasing cross-protective immunity from smallpox vaccination and recent ecologic alterations likely contribute to increased monkeypox outbreaks in Central Africa. High fatality rates associated with monkeypox virus clade I also are a local and international concern. Ongoing investigations of zoonotic sources and environmental changes that increase human exposure could inform practices to prevent monkeypox expansion into local communities and beyond endemic areas.
format Online
Article
Text
id pubmed-9707566
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-97075662022-12-09 National Monkeypox Surveillance, Central African Republic, 2001–2021 Besombes, Camille Mbrenga, Festus Schaeffer, Laura Malaka, Christian Gonofio, Ella Landier, Jordi Vickos, Ulrich Konamna, Xavier Selekon, Benjamin Dankpea, Joella Namsenei Von Platen, Cassandre Houndjahoue, Franck Gislain Ouaïmon, Daniel Sylver Hassanin, Alexandre Berthet, Nicolas Manuguerra, Jean-Claude Gessain, Antoine Fontanet, Arnaud Nakouné-Yandoko, Emmanuel Emerg Infect Dis Research We analyzed monkeypox disease surveillance in Central African Republic (CAR) during 2001–2021. Surveillance data show 95 suspected outbreaks, 40 of which were confirmed as monkeypox, comprising 99 confirmed and 61 suspected monkeypox cases. After 2018, CAR’s annual rate of confirmed outbreaks increased, and 65% of outbreaks occurred in 2 forested regions bordering the Democratic Republic of the Congo. The median patient age for confirmed cases was 15.5 years. The overall case-fatality ratio was 7.5% (12/160) for confirmed and suspected cases, 9.6% (8/83) for children <16 years of age. Decreasing cross-protective immunity from smallpox vaccination and recent ecologic alterations likely contribute to increased monkeypox outbreaks in Central Africa. High fatality rates associated with monkeypox virus clade I also are a local and international concern. Ongoing investigations of zoonotic sources and environmental changes that increase human exposure could inform practices to prevent monkeypox expansion into local communities and beyond endemic areas. Centers for Disease Control and Prevention 2022-12 /pmc/articles/PMC9707566/ /pubmed/36328951 http://dx.doi.org/10.3201/eid2812.220897 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research
Besombes, Camille
Mbrenga, Festus
Schaeffer, Laura
Malaka, Christian
Gonofio, Ella
Landier, Jordi
Vickos, Ulrich
Konamna, Xavier
Selekon, Benjamin
Dankpea, Joella Namsenei
Von Platen, Cassandre
Houndjahoue, Franck Gislain
Ouaïmon, Daniel Sylver
Hassanin, Alexandre
Berthet, Nicolas
Manuguerra, Jean-Claude
Gessain, Antoine
Fontanet, Arnaud
Nakouné-Yandoko, Emmanuel
National Monkeypox Surveillance, Central African Republic, 2001–2021
title National Monkeypox Surveillance, Central African Republic, 2001–2021
title_full National Monkeypox Surveillance, Central African Republic, 2001–2021
title_fullStr National Monkeypox Surveillance, Central African Republic, 2001–2021
title_full_unstemmed National Monkeypox Surveillance, Central African Republic, 2001–2021
title_short National Monkeypox Surveillance, Central African Republic, 2001–2021
title_sort national monkeypox surveillance, central african republic, 2001–2021
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707566/
https://www.ncbi.nlm.nih.gov/pubmed/36328951
http://dx.doi.org/10.3201/eid2812.220897
work_keys_str_mv AT besombescamille nationalmonkeypoxsurveillancecentralafricanrepublic20012021
AT mbrengafestus nationalmonkeypoxsurveillancecentralafricanrepublic20012021
AT schaefferlaura nationalmonkeypoxsurveillancecentralafricanrepublic20012021
AT malakachristian nationalmonkeypoxsurveillancecentralafricanrepublic20012021
AT gonofioella nationalmonkeypoxsurveillancecentralafricanrepublic20012021
AT landierjordi nationalmonkeypoxsurveillancecentralafricanrepublic20012021
AT vickosulrich nationalmonkeypoxsurveillancecentralafricanrepublic20012021
AT konamnaxavier nationalmonkeypoxsurveillancecentralafricanrepublic20012021
AT selekonbenjamin nationalmonkeypoxsurveillancecentralafricanrepublic20012021
AT dankpeajoellanamsenei nationalmonkeypoxsurveillancecentralafricanrepublic20012021
AT vonplatencassandre nationalmonkeypoxsurveillancecentralafricanrepublic20012021
AT houndjahouefranckgislain nationalmonkeypoxsurveillancecentralafricanrepublic20012021
AT ouaimondanielsylver nationalmonkeypoxsurveillancecentralafricanrepublic20012021
AT hassaninalexandre nationalmonkeypoxsurveillancecentralafricanrepublic20012021
AT berthetnicolas nationalmonkeypoxsurveillancecentralafricanrepublic20012021
AT manuguerrajeanclaude nationalmonkeypoxsurveillancecentralafricanrepublic20012021
AT gessainantoine nationalmonkeypoxsurveillancecentralafricanrepublic20012021
AT fontanetarnaud nationalmonkeypoxsurveillancecentralafricanrepublic20012021
AT nakouneyandokoemmanuel nationalmonkeypoxsurveillancecentralafricanrepublic20012021